Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Join this 38-minute webinar to learn about biomarker discoveries from the HEALEY ALS Platform Trial, presented by James Berry, MD, MPH and Eric Macklin, PhD from Massachusetts General Hospital. Explore the latest findings on biomarker applications in ALS research, with special emphasis on home spirometry as a monitoring tool for disease progression. Gain insights into how these biomarkers are being utilized to advance understanding of amyotrophic lateral sclerosis and improve clinical trial methodologies. Participate in a live Q&A session where the presenters address audience questions about the research findings and their implications for ALS treatment development. Access additional resources through the Mass General website to stay informed about future Platform Trial webinars and sign up for the ALS Link newsletter to receive ongoing updates about research from the Sean M. Healey & AMG Center for ALS.
